DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of “Hold” by Brokerages

DocGo Inc. (NASDAQ:DCGO) has earned an average recommendation of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $2.3750.

Several analysts have issued reports on the company. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Wall Street Zen upgraded DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th.

DocGo Stock Up 1.0%

Shares of DocGo stock opened at $0.58 on Friday. The stock has a market cap of $57.35 million, a P/E ratio of -0.30 and a beta of 0.99. DocGo has a 12-month low of $0.45 and a 12-month high of $1.76. The business’s 50 day moving average is $0.59 and its 200-day moving average is $0.64.

DocGo (NASDAQ:DCGO) last issued its earnings results on Monday, May 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). The firm had revenue of $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. On average, sell-side analysts expect that DocGo will post -0.12 EPS for the current year.

Hedge Funds Weigh In On DocGo

Several large investors have recently modified their holdings of the stock. Geode Capital Management LLC raised its holdings in DocGo by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock valued at $1,984,000 after acquiring an additional 73,900 shares during the period. State Street Corp grew its position in shares of DocGo by 2.0% in the fourth quarter. State Street Corp now owns 1,969,603 shares of the company’s stock valued at $1,729,000 after purchasing an additional 39,125 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of DocGo by 167.1% in the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after purchasing an additional 944,826 shares during the last quarter. BlackRock Inc. bought a new position in shares of DocGo during the second quarter worth approximately $750,000. Finally, Isthmus Partners LLC increased its stake in shares of DocGo by 14.0% during the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after purchasing an additional 124,211 shares during the period. 56.44% of the stock is owned by institutional investors.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.